Search
Search Funnelback University
- Refined by:
- Format: pdf
41 -
60 of
61
search results for news |u:www.enterprise.cam.ac.uk
Fully-matching results
-
Annual Review 2009 CommercialisationfortheBenefitofSociety Chief…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2008-2009-final.pdf9 Mar 2010: will continue to help improve the efficiency of new. builds and reduce costs. ... supporting new innovations and ventures. £62 million raised by 22 of our portfoliocompanies. -
Cambridge Enterprise LimitedUniversity of Cambridge10 Trumpington…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2007-2008-final.pdf23 Mar 2009: Equity. Transactions. With. Existing. Companies. With. New. Companies. 4 Annual Review 2007–2008. ... particular expertise and equipment in this area. Highlights 124 new consultancy disclosures received. -
LGR5 monoclonal antibody for cancer immunotherapy
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2357211 Jul 2024: LGR5 monoclonal antibody for cancerimmunotherapy. Background. In 2020, there were 1.9 million new cases of colorectal cancer, which is the 3rdmost common cancer worldwide. ... As a therapeutic target, LGR5 is relatively new but has been validated in a -
Annual Review 2022 Contents Foreword From the Chair Investment ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2023/07/Cambridge_Enterprise_2022_Annual_Review_FINAL-compressed_1.pdf3 Jul 2023: What could be truly new at an 800-year-old university? More than you could ever imagine. ... Investments totalling £10.85 million were approved in 21 businesses: 10 new and 11 follow-on. -
MAT2A inhibitors to treat BK polyomavirus disease
https://www.enterprise.cam.ac.uk/content-to-pdf/?postid=2810211 Jul 2024: The groundbreakingdiscovery opens new avenues for antiviral drug development and offers apromising therapeutic option for BKPyV-associated diseases, addressing thelimitations of available treatments. ... Taken together, these resultshighlight the -
PowerPoint Presentation
https://www.enterprise.cam.ac.uk/wp-content/uploads/2021/11/Marketing-Sheet_Low-loss-high-speed-data-transmission_Mol-7671-20_18-11-2021.pdf18 Nov 2021: the University of Cambridge have developed a new data transmission design based on a pair of Goubau Lines – metallic tracks or wires with a carefully defined separation, tailored to the frequency ... By using an appropriate antenna as a “launcher” -
Annual Review 2018 Contents Who we are and what ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2019/01/Annual-Review-2018.pdf28 Jan 2019: We help create and support new spin-out companies based on University intellectual property and people. ... 20 Cambridge Enterprise Annual Review. Case studyA new vision for saving glaucoma patients’ eyesight. -
Annual Review 2012 From the Pro-Vice-Chancellor(Research) In…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2012-web1.pdf11 Jan 2013: a perceived reluctance to adopt new technologies. Despite this, Amantys has succeeded by. ... opportunity to have a ready source of human cells. for testing new therapies. -
Golden Shares & Anti-dilution ProvisionsTom Hockaday, CEO, Isis…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/12/Golden-Shares-and-Anti-Dilution-Provisions-Jun15.pdf15 Jun 2015: Most recently a new model around perpetual anti-dilution in the form of a ‘Golden Share’ has been proposed as discussed below. ... In this way the golden share proposal may be welcomed insofar as it is a new idea, but one with uncertain benefits and -
Annual Review2020 /Where ideas thrive 2 Cambridge Enterprise Annual…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/01/Cambridge-Enterprise-Annual-Review-2020.pdf12 Mar 2021: Many also want to learn about new and ground-breaking technologies and companies originating from the University of Cambridge. ... Launched in 2018, Bad News has now been played over a million times. -
Annual Review 2015 Cambridge Enterprise LimitedUniversity of…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/Annual_Report_v21_040116_screen.pdf4 Jan 2016: Among our new investments and agreements were those with Professor Steve Young, a pioneer in the field of spoken dialogue management, whose company VocalIQ (p. ... team. We support academics and researchers to bring the most exciting ideas to market, -
Annual Review 2016 111 In 2006 Cambridge Enterprise Limited ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/2016_Annual_Report_corrected.pdf6 Mar 2017: The new technology developed in the University and licensed to Eight19 in 2016 promises enhanced silicon solar cell e¢ciencies. ... Providing advice to an external customer as a new consultant can be daunting for researchers. -
Annual Review 2013 From the Pro-Vice-Chancellor(Research) In…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2013-web.pdf6 Jan 2014: achieves a real and. meaningful impact on. society, whether through. new innovations for. ... a revolutionary new treatment for thrombosis; sales. of the quantum modelling software CASTEP passing. -
Annual Review 2014 Cover image: With the threat of ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/annual-report-screen-14.pdf7 Jan 2015: racing cars, or a new flower seed mix to help bees survive and flourish. ... Those containing active mixtures can be isolated to find rare cells or molecules that cause disease or produce a new medicine. -
CE Annual Review 2010-2011:A4
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/ce-annual-review-2010-2011-web.pdf19 Dec 2011: 440 disclosures comprising 154 IP disclosures, 232 consultancy. disclosures and 54 new business ideas. ... to new premises, and won a number of awards, including the Medical Futures Innovation Award. -
/Where ideas thrive Our 2021 story Highlights from our ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2023/07/Cambridge-Enterprise-Annual-Review-2021-compressed.pdf5 Jul 2023: Apollo is now advancing into clinical development as well as identifying new programmes. ... profi le. Evidence included scientifi c papers, government reports, and local news articles. -
CUE Annual Review 06-07:CUE Annual Review 06-07
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/cambridgeenterpriseannualreview2006-07.pdf21 Apr 2008: £750,000 was invested in new companies. 72 companies in Cambridge Enterprise equityportfolio. ... www.camfridge.com. Case StudyCase Study. Seed Funds. Practical Support for New Ventures. -
Annual Review 2010 From the Pro-Vice-Chancellor(Research) This year…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2015/04/2009-2010-annual-review-final.pdf6 Jan 2011: concept fund. 209 consultancy disclosures received (new consultancy projects). 165 consultancy agreements signed. ... collaboration,providing expert advice through paid consultancy, licensing for commercialisation,creating a new. -
Annual Review2019 /Where ideas thrive 2 Cambridge Enterprise Annual…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2020/03/Cambridge-Enterprise-Annual-Review-2019-1.pdf4 Mar 2020: PolyProx Therapeutics exists to develop a new class of drugs, called Polyproxin molecules. ... PolyProx Therapeutics A new class of drugs to halt difficult-to-drug cancers. -
Annual Review 2022 Contents Foreword From the Chair Investment ...
https://www.enterprise.cam.ac.uk/wp-content/uploads/2024/03/Cambridge_Enterprise_2022_Annual_Review_FINAL-compressed_1.pdf26 Mar 2024: What could be truly new at an 800-year-old university? More than you could ever imagine. ... Investments totalling £10.85 million were approved in 21 businesses: 10 new and 11 follow-on.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.